- Home
- TECH vs CFR Comparison
TECH vs CFR Comparison
Compare TECH & CFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- CFR
- Stock Information
- Founded
- TECH 1976
- CFR 1868
- Country
- TECH United States
- CFR United States
- Employees
- TECH N/A
- CFR N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- CFR Major Banks
- Sector
- TECH Health Care
- CFR Finance
- Exchange
- TECH Nasdaq
- CFR Nasdaq
- Market Cap
- TECH 7.8B
- CFR 7.9B
- IPO Year
- TECH 1989
- CFR N/A
- Fundamental
- Price
- TECH $49.15
- CFR $131.23
- Analyst Decision
- TECH Buy
- CFR Hold
- Analyst Count
- TECH 10
- CFR 15
- Target Price
- TECH $73.44
- CFR $133.13
- AVG Volume (30 Days)
- TECH 2.3M
- CFR 367.4K
- Earning Date
- TECH 05-07-2025
- CFR 05-01-2025
- Dividend Yield
- TECH 0.65%
- CFR 3.05%
- EPS Growth
- TECH N/A
- CFR 7.71
- EPS
- TECH 0.83
- CFR 9.11
- Revenue
- TECH $1,208,770,000.00
- CFR $2,038,108,000.00
- Revenue This Year
- TECH $8.19
- CFR $11.62
- Revenue Next Year
- TECH $8.61
- CFR $3.90
- P/E Ratio
- TECH $59.07
- CFR $14.41
- Revenue Growth
- TECH 4.72
- CFR 5.45
- 52 Week Low
- TECH $46.44
- CFR $94.09
- 52 Week High
- TECH $85.57
- CFR $147.64
- Technical
- Relative Strength Index (RSI)
- TECH 44.74
- CFR 68.66
- Support Level
- TECH $46.35
- CFR $129.05
- Resistance Level
- TECH $54.40
- CFR $131.82
- Average True Range (ATR)
- TECH 2.17
- CFR 2.52
- MACD
- TECH 0.27
- CFR 1.38
- Stochastic Oscillator
- TECH 34.78
- CFR 96.63
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
About CFR Cullen/Frost Bankers Inc.
Cullen/Frost is a regional US bank with around $50 billion in assets (as of 2024 year-end), and it focuses exclusively on the Texas market. The bank has deep expertise in this market. It has implemented a relationship-based approach to banking that has garnered a strong market share in San Antonio. Cullen/Frost is also expanding into Houston, Dallas, and Austin market regions through branch openings. The bank's sweet spot is small to medium-size Texas-based commercial clients.